SCHEMBL7497653

SCHEMBL7497653

COCC1CN(S(=O)(=O)c2cc3ccc(Cl)cc3s2)CC(=O)N1Cc1cc2cnccc2n1C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.58
F2 P00734 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7497659 1.00 F10 (0.58) F10F2
SCHEMBL1386589 0.83 F10 (0.71) F10F2
SCHEMBL1386557 0.82 F10 (0.68) F10F2
SCHEMBL1385061 0.82 F10 (0.68) F10F2
SCHEMBL1384706 0.79 F10 (0.53) F10
SCHEMBL1384704 0.79 F10 (0.53) F10
SCHEMBL7144387 0.79 F10 (0.51) F10
SCHEMBL1385894 0.79 F10 (0.45) F10F2
SCHEMBL1385891 0.79 F10 (0.45) F10F2
SCHEMBL7149149 0.76 F10 (0.49) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP disclosed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO disclosed